Login
$TEAM
$149.30 -$0.64 (0.43%) After hours

$TEAM SEC Filings

Filed On Filing
13 Nov 2026 Form 4: Cannon-Brookes Michael, Director

Bought 13,400 shares ($2M)

13 Nov 2026 SCHEDULE 13G/A
12 Nov 2026 Form 4: Cannon-Brookes Michael, Director

Bought 13,400 shares ($2.01M)

06 Nov 2026 10-Q
05 Nov 2026 8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation

Remaining performance obligations of $4,746 million, up 44% year-over-year

15 Oct 2026 144
14 Oct 2026 ARS
14 Oct 2026 DEFA14A
14 Oct 2026 Proxy statement: annual meeting on December 1, 2026

CEO pay $57K, up 5.7% · say-on-pay vote

13 Oct 2026 Form 4: Liu Gene, Chief Accounting Officer

Sold 337 shares ($70.8K)

13 Oct 2026 144
22 Sep 2026 Form 4: Duffy Brian, Chief Revenue Officer

Received 51,549 shares as a grant or award

22 Sep 2026 Form 4: Chuong James, Chief Financial Officer

Received 6,374 shares as a grant or award

31 Aug 2026 Form 4: Liu Gene, Chief Accounting Officer

Sold 939 shares ($178K)

27 Aug 2026 144
20 Aug 2026 Form 4: Chuong James, Chief Financial Officer

Sold 9,054 shares ($1.56M)

20 Aug 2026 Form 4: Duffy Brian, Chief Revenue Officer

Sold 1,851 shares ($319K)

20 Aug 2026 Form 4: Liu Gene, Chief Accounting Officer

Sold 1,125 shares ($197K)

19 Aug 2026 144
19 Aug 2026 144

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support